These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 3717976)
61. Razoxane in the treatment of psoriasis. Hill GW; Roach M Br J Dermatol; 1980 Nov; 103(5):583-5. PubMed ID: 7437323 [No Abstract] [Full Text] [Related]
62. Reappraisal of the use of methotrexate in rheumatic disease. Willkens RF Am J Med; 1983 Oct; 75(4B):19-25. PubMed ID: 6356904 [TBL] [Abstract][Full Text] [Related]
63. Absorption of methotrexate and hepatotoxicity. Dubin HV; Harrell ER JAMA; 1969 Nov; 210(6):1104. PubMed ID: 5394437 [No Abstract] [Full Text] [Related]
64. Radioimmunoassayable methotrexate concentrations in plasma and skin exudate of patients with psoriasis. Boomla K; Aherne GW; Greaves MW; Quinton M Clin Exp Dermatol; 1979 Dec; 4(4):457-63. PubMed ID: 535174 [No Abstract] [Full Text] [Related]
70. Assay of therapeutic doses of methotrexate in body fluids of patients with psoriasis. Noble WC; White PM; Baker H J Invest Dermatol; 1975 Feb; 64(2):69-76. PubMed ID: 1123553 [TBL] [Abstract][Full Text] [Related]
71. Study of psoriatic epidermal cell kinetics and cell death after oral methotrexate. Newton JA; Camplejohn RS; Bowyer C; McGibbon DH; Wright NA Dermatologica; 1985; 171(6):469-73. PubMed ID: 4092803 [TBL] [Abstract][Full Text] [Related]
72. [Practical aspects of the cytostatic therapy of psoriasis]. Rassner G Z Hautkr; 1976 Jun; 51(12):499-506. PubMed ID: 60007 [No Abstract] [Full Text] [Related]
73. Erosion of psoriatic plaques after chronic methotrexate administration. Kaplan DL; Olsen EA Int J Dermatol; 1988; 27(1):59-62. PubMed ID: 3346128 [TBL] [Abstract][Full Text] [Related]
74. Clinical pharmacokinetics of methotrexate in children. Wang YM; Fujimoto T Clin Pharmacokinet; 1984; 9(4):335-48. PubMed ID: 6380871 [TBL] [Abstract][Full Text] [Related]
75. Methotrexate uptake by psoriatic epidermis. Taylor JR; Halprin KM Br J Dermatol; 1977 Feb; 96(2):167-70. PubMed ID: 320999 [TBL] [Abstract][Full Text] [Related]
76. Liver damage and methotrexate. Baker H Br Med J; 1971 Jun; 2(5764):776. PubMed ID: 5090795 [No Abstract] [Full Text] [Related]
77. Pharmacokinetics of methotrexate administered via the hepatic artery. Ignoffo RJ; Oie S; Friedman MA Cancer Chemother Pharmacol; 1981; 5(4):217-20. PubMed ID: 7261249 [TBL] [Abstract][Full Text] [Related]
78. Utilizing Fibrosis-4 score to assess risk for hepatic fibrosis in patients with psoriasis on methotrexate. Yim E; Deutsch A; Nazarian RS; McLellan BN; Espinoza D; Wolkoff AW; Cohen SR Int J Dermatol; 2021 Mar; 60(3):e100-e101. PubMed ID: 32989752 [No Abstract] [Full Text] [Related]
79. Azaribine in the treatment of psoriasis. Dubin HV; Harrell ER Ann Intern Med; 1971 May; 74(5):797-8. PubMed ID: 5559450 [No Abstract] [Full Text] [Related]